Send me a link:

*Text messaging rates may apply.

 Dow Down 0.28% Nasdaq Down 0.17%

Avanir Pharmaceuticals, Inc. (AVNR)

-NasdaqGS
5.32 0.07(1.30%) Jul 21, 4:00PM EDT
Prev Close:5.39
Open:5.41
Bid:4.32 x 500
Ask:5.42 x 4600
1y Target Est:9.20
Beta:1.07
Next Earnings Date: 5-Aug-14AVNR Earnings announcement
Day's Range:5.28 - 5.44
52wk Range:2.62 - 6.00
Volume:1,465,109
Avg Vol (3m):2,891,970
Market Cap:850.29M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AVNR

Comparison

Symbol% ChgMkt Cap
AVNRDown 1.30%850.29M
BMY81.07B
LLY68.27B
GSK128.51B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-0.30
Quarterly EPS Est (Jun-14) :-0.07
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-0.32

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback